{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:05:04Z","timestamp":1780056304351,"version":"3.54.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2012,2,3]],"date-time":"2012-02-03T00:00:00Z","timestamp":1328227200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0030854","type":"journal-article","created":{"date-parts":[[2012,2,3]],"date-time":"2012-02-03T22:00:16Z","timestamp":1328306416000},"page":"e30854","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["Noradrenergic \u03b11 Receptor Antagonist Treatment Attenuates Positive Subjective Effects of Cocaine in Humans: A Randomized Trial"],"prefix":"10.1371","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct01062945","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Thomas F.","family":"Newton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"De La Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin N.","family":"Haile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,2,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.ps.40.020189.001203","article-title":"Brain dopamine and reward.","volume":"40","author":"RA Wise","year":"1989","journal-title":"Annu Rev Psychol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0376-8716(81)90088-0","article-title":"Effects of antipsychotic compounds in rhesus monkeys given a choice between cocaine and food.","volume":"8","author":"WL Woolverton","year":"1981","journal-title":"Drug Alcohol Depend"},{"key":"ref3","article-title":"Dopamine agonists for cocaine dependence (Cochrane Review).","volume":"4","author":"BG Soares","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.npp.1300392","article-title":"Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.","volume":"29","author":"J Grabowski","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2008.10.016","article-title":"Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.","volume":"101","author":"ME Mooney","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1360-0443.1991.tb01748.x","article-title":"History of abuse liability testing in humans.","volume":"86","author":"DR Jasinski","year":"1991","journal-title":"British Journal of Addiction"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.npp.1301263","article-title":"There and back again: a tale of norepinephrine and drug addiction.","volume":"32","author":"D Weinshenker","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1523\/JNEUROSCI.22-07-02873.2002","article-title":"Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates.","volume":"22","author":"C Drouin","year":"2002","journal-title":"J Neurosci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1523\/JNEUROSCI.18-07-02729.1998","article-title":"Importance of the Noradrenaline-Dopamine Coupling in the Locomotor Activating Effects of D-Amphetamine.","volume":"18","author":"L Darracq","year":"1998","journal-title":"J Neurosci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/syn.10023","article-title":"Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics.","volume":"43","author":"C Drouin","year":"2002","journal-title":"Synapse"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-2999(85)90156-6","article-title":"Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice.","volume":"116","author":"AM Snoddy","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.biopsych.2005.02.003","article-title":"Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking.","volume":"57","author":"XY Zhang","year":"2005","journal-title":"Biol Psychiatry"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00003088-198005040-00004","article-title":"Clinical pharmacokinetics of prazosin.","volume":"5","author":"P Jaillon","year":"1980","journal-title":"Clin Pharmacokinet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2125.1982.tb01439.x","article-title":"A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.","volume":"13","author":"HL Elliott","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00268-002-6667-z","article-title":"Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma.","volume":"26","author":"C Prys-Roberts","year":"2002","journal-title":"World J Surg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00000542-199108000-00013","article-title":"Central alpha 1-adrenoceptor stimulation functionally antagonizes the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist.","volume":"75","author":"TZ Guo","year":"1991","journal-title":"Anesthesiology"},{"key":"ref17","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.","volume":"59","author":"DV Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","article-title":"Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients.","volume":"67","author":"AT Beck","year":"1996","journal-title":"J Pers Assess"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pbb.2005.07.012","article-title":"Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects.","volume":"82","author":"TF Newton","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF01062108","article-title":"Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level\u2013time curve.","volume":"6","author":"WL Chiou","year":"1978","journal-title":"J Pharmacokinet Biopharm"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1464-410x.2001.02032.x","article-title":"A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia.","volume":"87","author":"RS Kirby","year":"2001","journal-title":"BJU Int"},{"key":"ref22","article-title":"Statistical Power Analysis for the Behavioral Science","author":"J Cohen","year":"1988"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings.","volume":"168","author":"Y Shaham","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0091-3057(87)90618-6","article-title":"Evaluation of the role of norepinephrine in the reinforcing effects of psychomotor stimulants in rhesus monkeys.","volume":"26","author":"WL Woolverton","year":"1987","journal-title":"Pharmacol Biochem Behav"},{"key":"ref25","first-page":"211","article-title":"Relationship between self-reported drug effects and their reinforcing effects: studies with stimulant drugs.","volume":"92","author":"MW Fischman","year":"1989","journal-title":"NIDA Res Monogr"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1360-0443.1991.tb01749.x","article-title":"Utility of subjective-effects measurements in assessing abuse liability of drugs in humans.","volume":"86","author":"MW Fischman","year":"1991","journal-title":"Br J Addict"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","article-title":"Controversies in translational research: drug self-administration.","volume":"199","author":"M Haney","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1749-6632.2002.tb04155.x","article-title":"Appetite suppressants as agonist substitution therapies for stimulant dependence.","volume":"965","author":"RB Rothman","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0306-4522(81)90051-8","article-title":"The intra-cortical trajectory of the coeruleo-cortical projection in the rat: a tangentially organized cortical afferent.","volume":"6","author":"JH Morrison","year":"1981","journal-title":"Neuroscience"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1038\/npp.2010.127","article-title":"Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine beta-hydroxylase.","volume":"35","author":"JP Schroeder","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2165\/11316710-000000000-00000","article-title":"Fixed-dose combinations as initial therapy for hypertension: a review of approved agents and a guide to patient selection.","volume":"69","author":"B Waeber","year":"2009","journal-title":"Drugs"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0030854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:20:27Z","timestamp":1589026827000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0030854"}},"subtitle":[],"editor":[{"given":"Bernard","family":"Le Foll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,2,3]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0030854","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,3]]}}}